**
The landscape of autism research in the United States is undergoing significant upheaval as Robert F. Kennedy Jr., Secretary of the Department of Health and Human Services (HHS), implements sweeping changes to the Interagency Autism Coordinating Committee (IACC). This reshuffle, which has raised eyebrows and sparked controversy, coincides with the establishment of a rival organisation aimed at promoting scientifically-backed research. As debates intensify, the implications for funding and policy around autism are profound.
Controversial Changes to the IACC
In late January, Kennedy appointed a new slate of members to the IACC, reducing the representation of autistic individuals and introducing several advocates known for their anti-vaccine stance. The committee, which plays a pivotal role in guiding nearly $2 billion in federal autism research funding, was originally established under the Combating Autism Act of 2006. Critics argue that Kennedy’s alterations signal a troubling return to outdated narratives, echoing the past framing of autism as an epidemic requiring eradication.
Originally, the IACC was mandated to include three autistic members; however, the current composition has drawn significant backlash, with only one autistic individual now serving among the ranks. This shift has left many in the autism community questioning the committee’s commitment to inclusive and representative governance. Matt Carey, a previous member, has labelled the current IACC a “sham,” suggesting it is tailored to produce findings that align with Kennedy’s controversial views.
Emergence of the Independent Autism Coordinating Committee
Amidst these changes, the Independent Autism Coordinating Committee (I-ACC) emerged on 3 March as a pro-science alternative, aimed at providing research recommendations to private donors and institutions. The formation of this new committee reflects a growing discontent within the autism advocacy community regarding the direction of federal efforts under Kennedy’s leadership.
While supporters of the I-ACC express hope for a more science-driven approach, concerns linger over its composition. Notably, it includes only one autistic member, raising alarms about the potential for a narrow perspective on autism research and treatment. Critics have pointed out that some members advocate for the controversial categorisation of “profound autism,” which many in the community argue lacks scientific merit and could further fragment autism advocacy.
The Broader Impact of Policy Shifts
The IACC’s recent changes and the establishment of the I-ACC come at a time when the conversation around autism is more critical than ever. With the federal committee’s meeting recently cancelled, the uncertainty surrounding its future functions has left many advocates feeling apprehensive about how research will be prioritised. Zoe Gross, director of advocacy at the Autistic Self Advocacy Network (ASAN), expressed fears that the federal committee might endorse funding for debunked theories, such as the discredited belief that vaccines cause autism.
Kennedy’s team has stated that the IACC will work to align autism research with contemporary scientific standards, yet many remain sceptical. The previous emphasis on harmful “treatments” such as bleach enemas and chelation therapy has left a dark legacy, casting doubt on the new committee’s intentions.
A Call for Genuine Representation
As the I-ACC begins its work, its leaders stress the importance of inclusivity and representation. David Mandell, a founding member of the I-ACC, noted that the committee’s formation was expedited, suggesting that it must actively seek to address gaps in representation and ensure that diverse voices are included in discussions about autism research.
The hope is that this new committee can set a definitive research agenda that counters misinformation and advocates for evidence-based practices. Mandell emphasised the necessity of grounding discussions in rigorous, validated sources, indicating a clear shift away from the ideologically driven narratives that have characterised some past approaches.
Why it Matters
The ongoing debates surrounding the IACC and the emergence of the I-ACC underscore a pivotal moment in autism advocacy and research. As the community grapples with the implications of these changes, the potential for funding and policy decisions to profoundly impact the lives of autistic individuals is significant. Ensuring that autistic voices are represented in these conversations is not merely a matter of inclusivity; it is essential for fostering a research environment that prioritises scientific integrity and genuine understanding of autism. The choices made today will reverberate throughout the future landscape of autism support, treatment, and advocacy.
